Robert Thomas Dechant - Sep 16, 2025 Form 4/A - Amendment Insider Report for IBEX Ltd (IBEX)

Role
Chief Executive Officer, Director
Signature
Lisa Lenstrohm, Attorney-in-Fact
Stock symbol
IBEX
Transactions as of
Sep 16, 2025
Transactions value $
$0
Form type
4/A - Amendment
Date filed
11/13/2025, 05:10 PM
Date Of Original Report
Sep 17, 2025
Previous filing
Sep 15, 2025
Next filing
Oct 2, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Dechant Robert Thomas Chief Executive Officer, Director C/O IBEX LIMITED, 1717 PENNSYLVANIA AVENUE NW, SUITE 825, WASHINGTON Lisa Lenstrohm, Attorney-in-Fact 2025-11-13 0001298255

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IBEX Stock Option (Right to Buy Common Shares) Options Exercise $0 -45K -100% $0.00 0 Sep 16, 2025 Common Shares 45K $19.00 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The acquisition and sale of the common shares underlying these options was previously reported on Form 4 on September 17, 2025. The exercise of the options was inadvertently not included in that Form 4 filing, so is now reported in this Amendment.
F2 The shares subject to this option are fully vested and exercisable.